Vitaspring Biomedical Co Stock Buy Hold or Sell Recommendation
| VSBC Stock | USD 1.00 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding VitaSpring Biomedical Co is 'Hold'. Macroaxis provides VitaSpring Biomedical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VSBC positions.
Check out VitaSpring Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as VitaSpring and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards VitaSpring Biomedical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
VitaSpring |
Execute VitaSpring Biomedical Buy or Sell Advice
The VitaSpring recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on VitaSpring Biomedical Co. Macroaxis does not own or have any residual interests in VitaSpring Biomedical Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute VitaSpring Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
VitaSpring Biomedical Trading Alerts and Improvement Suggestions
| VitaSpring Biomedical generated a negative expected return over the last 90 days | |
| VitaSpring Biomedical has some characteristics of a very speculative penny stock | |
| About 59.0% of the company outstanding shares are owned by insiders |
VitaSpring Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to VitaSpring Biomedical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that VitaSpring Biomedical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a VitaSpring pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
VitaSpring Biomedical Volatility Alert
At this time VitaSpring Biomedical Co exhibits very low volatility. VitaSpring Biomedical Co is a potential penny stock. Although VitaSpring Biomedical may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in VitaSpring Biomedical Co. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on VitaSpring instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.VitaSpring Biomedical Fundamentals Vs Peers
Comparing VitaSpring Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze VitaSpring Biomedical's direct or indirect competition across all of the common fundamentals between VitaSpring Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as VitaSpring Biomedical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of VitaSpring Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing VitaSpring Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare VitaSpring Biomedical to competition |
| Fundamentals | VitaSpring Biomedical | Peer Average |
| Return On Equity | 0.84 | -0.31 |
| Return On Asset | 0.41 | -0.14 |
| Profit Margin | 0.19 % | (1.27) % |
| Operating Margin | 0.24 % | (5.51) % |
| Current Valuation | 2.89 B | 16.62 B |
| Shares Outstanding | 206.52 M | 571.82 M |
| Shares Owned By Insiders | 58.70 % | 10.09 % |
| Price To Book | 1,622 X | 9.51 X |
| Price To Sales | 558.27 X | 11.42 X |
| Revenue | 5.61 M | 9.43 B |
| Gross Profit | 2.06 M | 27.38 B |
| EBITDA | 1.49 M | 3.9 B |
| Net Income | 1.26 M | 570.98 M |
| Cash And Equivalents | 21.59 K | 2.7 B |
| Total Debt | 375.5 K | 5.32 B |
| Debt To Equity | 0.21 % | 48.70 % |
| Current Ratio | 4.23 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | 84.81 K | 971.22 M |
| Number Of Employees | 3 | 18.84 K |
| Beta | 1.43 | -0.15 |
| Market Capitalization | 3.1 B | 19.03 B |
| Total Asset | 3.6 M | 29.47 B |
| Net Asset | 3.6 M |
VitaSpring Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as VitaSpring . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About VitaSpring Biomedical Buy or Sell Advice
When is the right time to buy or sell VitaSpring Biomedical Co? Buying financial instruments such as VitaSpring Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having VitaSpring Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in VitaSpring Pink Sheet
VitaSpring Biomedical financial ratios help investors to determine whether VitaSpring Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VitaSpring with respect to the benefits of owning VitaSpring Biomedical security.